DJ DexCom Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of DexCom Inc. $(DXCM)$ slipped 2.69% to $85.99 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.76% to 5,849.72 and Dow Jones Industrial Average falling 1.48% to 43,191.24.
DexCom Inc. closed 39.44% short of its 52-week high of $142.00, which the company achieved on March 26th.
The stock underperformed when compared to some of its competitors Monday, as Abbott Laboratories $(ABT)$ rose 1.60% to $140.22 and Insulet Corp. $(PODD)$ rose 0.14% to $272.64.
Trading volume (3.9 M) eclipsed its 50-day average volume of 3.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 3, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 03, 2025 16:55 ET (21:55 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。